| Central nervous system Diseases |
1.89E-47 |
459/3069 |
| Brain diseases |
6.73E-46 |
435/2880 |
| Schizophrenia |
6.25E-43 |
203/914 |
| Schizophrenia and disorders with psychotic features |
9.56E-43 |
203/918 |
| Neurodegenerative diseases |
2.74E-39 |
336/2104 |
| Mental disorders |
3.50E-39 |
281/1614 |
| Nervous system diseases |
3.50E-39 |
665/5522 |
| Psychiatry and psychology |
8.79E-36 |
307/1919 |
| Dementia |
9.48E-32 |
255/1536 |
| Tauopathies |
6.13E-29 |
206/1166 |
| Alzheimer's disease |
2.04E-27 |
201/1153 |
| Virus diseases* |
1.68E-17 |
215/1531 |
| TDP-43 proteinopathies |
2.55E-17 |
54/180 |
| Amyotrophic lateral sclerosis |
9.00E-17 |
53/179 |
| Heredodegenerative disorders, nervous system |
1.19E-16 |
163/1064 |
| Glioblastoma |
7.15E-16 |
311/2579 |
| Astrocytoma |
9.92E-16 |
315/2628 |
| Epilepsy |
1.09E-15 |
90/455 |
| Basal ganglia diseases |
5.70E-15 |
129/799 |
| Movement disorders |
3.01E-14 |
135/871 |
| Neuromuscular diseases |
1.31E-13 |
176/1278 |
| Spinal cord diseases |
2.14E-13 |
72/352 |
| Neurologic manifestations |
2.38E-13 |
204/1566 |
| Motor neuron disease |
2.76E-13 |
59/257 |
| Tay-Sachs disease |
8.24E-13 |
12/12 |
| Dyskinesias |
8.98E-13 |
117/745 |
| Brain diseases, metabolic |
1.71E-12 |
62/290 |
| Bacterial infections and mycoses* |
1.76E-12 |
175/1307 |
| Glioma |
2.44E-12 |
534/5313 |
| RNA virus infections* |
4.27E-12 |
148/1055 |
| Brain diseases, metabolic, inborn |
9.98E-12 |
59/279 |
| Neoplasms, neuroepithelial |
1.00E-11 |
554/5596 |
| Infection* |
7.58E-11 |
157/1185 |
| Down syndrome |
1.94E-10 |
42/173 |
| Huntington's disease |
4.97E-09 |
75/461 |
| Lysosomal storage diseases, Nervous system |
5.14E-09 |
23/67 |
| Parkinsonian disorders |
2.45E-05 |
58/405 |
| Frontotemporal lobar Degeneration |
2.24E-04 |
18/80 |
| Frontotemporal dementia |
2.24E-04 |
18/80 |
